Look at cash generated by operations and net income for the last three years.
The risk is delisting.
But even if delisted you can sell OTC.
These companies will restructure I think. Even at reduced margins there's still huge valuation gap.
DYOR
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Look at cash generated by operations and net income for the last three years.
The risk is delisting.
But even if delisted you can sell OTC.
These companies will restructure I think. Even at reduced margins there's still huge valuation gap.
DYOR